These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38789451)

  • 1. The clinical and economic costs associated with regional disparities in varicella vaccine coverage in Italy over 50 years (2020-2070).
    Lang JC; Samant S; Cook JR; Ranjan S; Senese F; Starnino S; Giuffrida S; Azzari C; Baldo V; Pawaskar M
    Sci Rep; 2024 May; 14(1):11929. PubMed ID: 38789451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case study.
    Kujawski SA; Burgess C; Agi O; Attias-Geva Z; Pillsbury M; Greenberg D; Bencina G; Pawaskar M
    Hum Vaccin Immunother; 2022 Nov; 18(6):2124784. PubMed ID: 36315970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological Impact and Cost-Effectiveness of Varicella Vaccination Strategies in the United Kingdom.
    Akpo EIH; Cristeau O; Hunjan M; Casabona G
    Clin Infect Dis; 2021 Dec; 73(11):e3617-e3626. PubMed ID: 33173938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland.
    Heininger U; Pillsbury M; Samant S; Lienert F; Guggisberg P; Gani R; O'Brien E; Pawaskar M
    Pediatr Infect Dis J; 2021 Jun; 40(6):e217-e221. PubMed ID: 33872276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella vaccination in Italy and Germany - different routes to success: a systematic review.
    Kauffmann F; Bechini A; Bonanni P; Casabona G; Wutzler P
    Expert Rev Vaccines; 2020 Sep; 19(9):843-869. PubMed ID: 32969747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An economic evaluation and incremental analysis of the cost effectiveness of three universal childhood varicella vaccination strategies for Ireland.
    Ahern S; Browne J; Murphy A; Teljeur C; Ryan M
    Vaccine; 2024 May; 42(14):3321-3332. PubMed ID: 38609807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy.
    Holl K; Sauboin C; Amodio E; Bonanni P; Gabutti G
    BMC Public Health; 2016 Oct; 16(1):1103. PubMed ID: 27769206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster.
    Littlewood KJ; Ouwens MJ; Sauboin C; Tehard B; Alain S; Denis F
    Clin Ther; 2015 Apr; 37(4):830-841.e7. PubMed ID: 25721380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Slovenia.
    Burgess C; Kujawski S; Lapornik A; Bencina G; Pawaskar M
    J Health Econ Outcomes Res; 2022; 9(2):95-102. PubMed ID: 36196453
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012.
    Tafuri S; Fortunato F; Cappelli MG; Cozza V; Bechini A; Bonanni P; Martinelli D; Prato R
    Hum Vaccin Immunother; 2015; 11(1):214-9. PubMed ID: 25483538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectiveness.
    Burgess C; Samant S; leFevre T; Schade Larsen C; Pawaskar M
    PLOS Glob Public Health; 2023; 3(4):e0001743. PubMed ID: 37018165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of universal vaccination against varicella in Italy.
    Bechini A; Boccalini S; Baldo V; Cocchio S; Castiglia P; Gallo T; Giuffrida S; Locuratolo F; Tafuri S; Martinelli D; Prato R; Amodio E; Vitale F; Bonanni P
    Hum Vaccin Immunother; 2015; 11(1):63-71. PubMed ID: 25483517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the combined MMRV Priorix-Tetra™ vaccine against varicella in a large Italian region: A case-control study.
    Fortunato F; Musco A; Iannelli G; Meola M; Luigi Lopalco P; Martinelli D
    Vaccine; 2024 Mar; 42(7):1608-1616. PubMed ID: 38341290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases.
    Bonanni P; Boccalini S; Bechini A; Banz K
    Vaccine; 2008 Oct; 26(44):5619-26. PubMed ID: 18723062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic value of childhood varicella vaccination in France and Germany.
    Coudeville L; Brunot A; Szucs TD; Dervaux B
    Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
    Wolff E; Widgren K; Scalia Tomba G; Roth A; Lep T; Andersson S
    PLoS One; 2021; 16(5):e0251644. PubMed ID: 33984060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness and budget impact of universal varicella vaccination in Russia.
    Marijam A; Safonova E; Scherbakov M; Shpeer E; Van Oorschot D; Rudakova A; Tatochenko V; Briko N
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045152. PubMed ID: 35258445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative efficacy of varicella vaccines: network meta-analysis of randomized controlled trials.
    Pawaskar M; Siddiqui MK; Takyar J; Sharma A; Fergie J
    Curr Med Res Opin; 2022 Oct; 38(10):1772-1782. PubMed ID: 35713564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial.
    Povey M; Henry O; Riise Bergsaker MA; Chlibek R; Esposito S; Flodmark CE; Gothefors L; Man S; Silfverdal SA; Štefkovičová M; Usonis V; Wysocki J; Gillard P; Prymula R
    Lancet Infect Dis; 2019 Mar; 19(3):287-297. PubMed ID: 30765242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.